[Non-pharmacological prevention of chronic kidney disease]

Guillaume Merckx1, Mélanie Somja1,2,3,4, Gwendoline Makalou1,2,3,4

  • 1Service de Néphrologie, CHU Liège, Belgique.

PubMed

Insights

Preventing chronic kidney disease (CKD) involves both medications and lifestyle changes. This article details non-medicinal approaches like diet and exercise to slow CKD progression.

Area of Science:

  • Nephrology
  • Public Health
  • Preventive Medicine

Background:

  • Chronic kidney disease (CKD) presents a significant global health challenge, contributing to cardiovascular complications and reduced quality of life.
  • Pharmacological interventions, including renin/angiotensin/aldosterone system blockers and SGLT2 inhibitors, are established CKD preventatives.
  • Emerging therapies like mineralocorticoid receptor antagonists and GLP-1 receptor agonists are under investigation for nephroprotection.

Purpose of the Study:

  • To comprehensively review and detail non-pharmacological strategies for the prevention and management of chronic kidney disease.
  • To highlight the importance of lifestyle modifications in conjunction with medical treatments for CKD.

Main Methods:

  • Review of current literature on non-medicinal approaches to CKD prevention.
  • Synthesis of evidence regarding hygienic-dietary measures, including smoking cessation, physical activity, and specific dietary interventions.
  • Discussion of the role of these non-pharmacological strategies in slowing CKD progression.

Main Results:

  • Non-pharmacological measures, such as smoking avoidance, regular physical activity, and tailored dietetics, are crucial components of CKD prevention.
  • These lifestyle interventions complement pharmacological treatments, offering a holistic approach to kidney health.
  • Optimizing these factors can significantly contribute to slowing the progression of chronic kidney disease.

Conclusions:

  • A multi-faceted approach combining pharmacological agents and non-pharmacological strategies is essential for effective CKD prevention and management.
  • Emphasis on lifestyle modifications, including diet and exercise, is vital for public health initiatives targeting chronic kidney disease.
  • Further research and clinical implementation of these non-medicinal approaches can improve patient outcomes and reduce the burden of CKD.

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
512